Aeras Hong Kong Limited
Hong Kong, Hong KongPurpose
to accelerate development and licensure of an improved TB vaccine for use in high burden countries
Grantee
Division
Global Health
Date
SEPTEMBER 2021
Region served
AMERICA,
ASIA
Committed amount
$8,450
Grant topic
Tuberculosis
Duration (months)
4
Grantee location
Hong Kong, Hong Kong
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.